LABCORP HOLDINGS INC (LH) Stock Price, Quote, News and Overview
NYSE:LH - New York Stock Exchange, Inc. - US5049221055 - Common Stock - Currency: USD
LH Quote, Performance and Key Statistics
NYSE:LH (5/21/2025, 9:48:08 AM)
246.455
-4.34 (-1.73%)
The current stock price of LH is 246.455 USD. In the past month the price increased by 13.87%. In the past year, price increased by 25.62%.
LH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 11.67 | 87.36B | ||
| CVS | CVS HEALTH CORP | 9.89 | 79.40B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.82 | 19.31B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 19.16 | 17.76B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 134.11 | 14.56B | ||
| HIMS | HIMS & HERS HEALTH INC | 90.43 | 13.96B | ||
| DVA | DAVITA INC | 15.58 | 11.07B | ||
| CHE | CHEMED CORP | 24.52 | 8.46B | ||
| CRVL | CORVEL CORP | 26.97 | 5.79B | ||
| OPCH | OPTION CARE HEALTH INC | 26.33 | 5.35B | ||
| GH | GUARDANT HEALTH INC | N/A | 4.81B | ||
| RDNT | RADNET INC | 283.38 | 4.46B |
Related stock screener links
About LH
Company Profile
Labcorp Holdings, Inc. engages in providing medical testing services. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Company Info
LABCORP HOLDINGS INC
358 S Main St
Burlington NORTH CAROLINA 27215 US
CEO: Adam H. Schechter
Employees: 65450
Phone: 13362291127
LABCORP HOLDINGS INC / LH FAQ
What is the stock price of LABCORP HOLDINGS INC today?
The current stock price of LH is 246.455 USD. The price decreased by -1.73% in the last trading session.
What is the ticker symbol for LABCORP HOLDINGS INC stock?
The exchange symbol of LABCORP HOLDINGS INC is LH and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is LH stock listed?
LH stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for LABCORP HOLDINGS INC stock?
29 analysts have analysed LH and the average price target is 277.93 USD. This implies a price increase of 12.77% is expected in the next year compared to the current price of 246.455. Check the LABCORP HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is LABCORP HOLDINGS INC worth?
LABCORP HOLDINGS INC (LH) has a market capitalization of 20.63B USD. This makes LH a Large Cap stock.
How many employees does LABCORP HOLDINGS INC have?
LABCORP HOLDINGS INC (LH) currently has 65450 employees.
What are the support and resistance levels for LABCORP HOLDINGS INC (LH) stock?
LABCORP HOLDINGS INC (LH) has a support level at 249.46 and a resistance level at 251.54. Check the full technical report for a detailed analysis of LH support and resistance levels.
Is LABCORP HOLDINGS INC (LH) expected to grow?
The Revenue of LABCORP HOLDINGS INC (LH) is expected to grow by 6.99% in the next year. Check the estimates tab for more information on the LH EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy LABCORP HOLDINGS INC (LH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LH, evaluating the profitability, health, valuation and growth aspects
- LABCORP HOLDINGS INC (LH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LABCORP HOLDINGS INC (LH) Sales and EPS estimates to see what analysts future expectations are.
- LABCORP HOLDINGS INC (LH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LABCORP HOLDINGS INC (LH) Insider and Institutional Ownership to learn about the owners and their transactions.
- LABCORP HOLDINGS INC (LH) Stock Chart to make your own analysis
- LABCORP HOLDINGS INC (LH) Latest news and press-releases to stay up to date.
Does LABCORP HOLDINGS INC (LH) stock pay dividends?
LABCORP HOLDINGS INC (LH) has a dividend yield of 1.17%. The yearly dividend amount is currently 2.91. Check the full fundamental report for a detailed analysis of LH dividend history, reliability and sustainability.
When does LABCORP HOLDINGS INC (LH) report earnings?
LABCORP HOLDINGS INC (LH) will report earnings on 2025-07-30.
What is the Price/Earnings (PE) ratio of LABCORP HOLDINGS INC (LH)?
The PE ratio for LABCORP HOLDINGS INC (LH) is 16.73. This is based on the reported non-GAAP earnings per share of 14.73 and the current share price of 246.455 USD. Check the full fundamental report for a full analysis of the valuation metrics for LH.
What is the Short Interest ratio of LABCORP HOLDINGS INC (LH) stock?
The outstanding short interest for LABCORP HOLDINGS INC (LH) is 3.53% of its float. Check the ownership tab for more information on the LH short interest.
LH Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to LH. When comparing the yearly performance of all stocks, LH is one of the better performing stocks in the market, outperforming 83.6% of all stocks.
LH Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to LH. LH has only an average score on both its financial health and profitability.
LH Financial Highlights
Over the last trailing twelve months LH reported a non-GAAP Earnings per Share(EPS) of 14.73. The EPS increased by 4.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.55% | ||
| ROA | 4.15% | ||
| ROE | 8.8% | ||
| Debt/Equity | 0.68 |
LH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to LH. The Buy consensus is the average rating of analysts ratings from 29 analysts.
For the next year, analysts expect an EPS growth of 13.77% and a revenue growth 6.99% for LH